Close
Cancer Type
Search result for "Solr search content"
Search Result for "bladder cancer"
Cancer Treatment
Bladder Cancer Surgery
Bladder cancer treatment often includes surgery to remove a cancerous tumor. At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our team regularly performs these complex procedures. Some bladder surgery affects your body’s ability to urinate. Our surgeons perform reconstructive procedures to restore function. Many patients can urinate on their own after surgery, even without a bladder.
provider
Robert Svatek, MD Urologic Oncology, Urology
Story
Bladder cancer is more advanced in South Texas, study finds
Bladder cancer is more aggressive and more advanced in South Texas residents than in many parts of the country, a study by the Mays Cancer Center indicates.
Clinical Trial
Identifying Influencing Factors in the Decision-Making Process for Bladder Cancer Patients
The study involves gathering information via one-on-one patient interviews, surveys and questionnaires so that we can better understand the patient decision-making process involved in bladder cancer treatment.
Cancer Treatment
Cancer Surgery
At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, you can receive expert surgical care close to your support network. Our team includes surgeons who are skilled in advanced techniques, removing complex tumors in sophisticated ways. The team’s expertise helps us treat many types of cancer with less impact on your daily life.
Clinical Trial
A Phase 1/2a Study of STM-416 Administered Intraoperatively to Patients Undergoing Transurethral Resection of Bladder Tumor (TURBT) for Recurrent High-Grade Papillary Bladder Cancer
This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.
Story
Bladder cancer patients respond well to new immunotherapy tested at Mays Cancer Center
According to the study, 53.4% of participants receiving NF were free of cancer at three months and 45.5% of patients continued to be cancer-free for at least 12 months.
Research & Publications
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.
Research & Publications